ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 239 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,260,000 | +11.1% | 82,909 | +22.7% | 0.02% | 0.0% |
| Q2 2018 | $1,134,000 | -20.8% | 67,560 | -23.0% | 0.02% | -25.0% |
| Q1 2018 | $1,432,000 | +124.5% | 87,760 | +76.0% | 0.02% | +118.2% |
| Q4 2017 | $638,000 | +131.2% | 49,860 | +122.0% | 0.01% | +120.0% |
| Q3 2017 | $276,000 | +36.0% | 22,460 | -18.3% | 0.01% | +66.7% |
| Q1 2015 | $203,000 | -41.2% | 27,500 | -63.7% | 0.00% | -50.0% |
| Q2 2014 | $345,000 | -48.0% | 75,700 | -48.2% | 0.01% | -50.0% |
| Q2 2013 | $664,000 | – | 146,199 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |